For example, the FAP gene–targeting tumor-derived exosomes-like nanovesicles (eNVs-FAP) could trigger potent and specific cytotoxic T lymphocyte (CTL) immune responses against tumor cells and FAP+ CAFs and remodel immunosuppressive TME in multiple models. The gene discussed is FAP; the disease is neoplasm.